{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:30:09Z","timestamp":1761129009326},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.eururo.2012.08.051","type":"journal-article","created":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T02:17:13Z","timestamp":1346465833000},"page":"166-167","source":"Crossref","is-referenced-by-count":2,"title":["\u03b1-Blockers and Antimuscarinics for Male Lower Urinary Tract Symptoms: The Search Goes On"],"prefix":"10.1016","volume":"63","author":[{"given":"Christian","family":"Gratzke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl-Erik","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2012.08.051_bib0005","unstructured":"Oelke M, Bachmann A, Descaueaud A, et al. Guidelines on the management of male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO). European Association of Urology Web site. http:\/\/www.uroweb.org\/gls\/pdf\/12_Male_LUTS_LR.pdf. Updated February 2012."},{"key":"10.1016\/j.eururo.2012.08.051_bib0010","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.eururo.2009.07.044","article-title":"A refocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literature","volume":"56","author":"Roosen","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.051_bib0015","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/ncpuro0836","article-title":"Pharmacology of alpha1-adrenoceptor antagonists in the lower urinary tract and central nervous system","volume":"4","author":"Andersson","year":"2007","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.eururo.2012.08.051_bib0020","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.eururo.2010.11.040","article-title":"Antimuscarinic mechanisms and the overactive detrusor: an update","volume":"59","author":"Andersson","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.051_bib0025","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.eururo.2007.12.007","article-title":"Cholinergic innervation and muscarinic receptors in the human prostate","volume":"54","author":"Witte","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.051_bib0030","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.juro.2010.03.104","article-title":"Spinal effects of the fesoterodine metabolite 5-hydroxymethyl tolterodine and\/or doxazosin in rats with or without partial urethral obstruction","volume":"184","author":"F\u00fcllhase","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2012.08.051_bib0035","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.eururo.2011.03.054","article-title":"The role of antimuscarinics in the management of men with symptoms of overactive bladder associated with concomitant bladder outlet obstruction: an update","volume":"60","author":"Athanasopoulos","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.051_bib0055","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.eururo.2012.07.003","article-title":"Solifenacin plus tamsulosin combination treatment in men with lower urinary tract symptoms and bladder outlet obstruction: a randomized, controlled trial","volume":"63","author":"Kaplan","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2012.08.051_bib0045","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1001\/jama.296.19.2319","article-title":"Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial","volume":"296","author":"Kaplan","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2012.08.051_bib0050","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.eururo.2005.05.015","article-title":"A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial","volume":"48","author":"Chapple","year":"2005","journal-title":"Eur Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283812010044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283812010044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T23:01:46Z","timestamp":1542754906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283812010044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0302283812010044"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2012.08.051","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}